Skip to main content

RVL Pharmaceuticals plc

RVLPDelisted Nov 20, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001739426

RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in RVL Pharmaceuticals plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
31
−4 vs. Q3 2021
Shares held
17.3M
+13.3M (+329.2%) vs. Q3 2021
Total value
$18.7M
+$6.80M (+57.3%) vs. Q3 2021
New holders
8
6 more added
Sold out
12
12 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 31 institutions
Q1 2021: 55 institutionsQ2 2021: 46 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 36 institutionsQ2 2022: 38 institutionsQ3 2022: 46 institutionsQ4 2022: 36 institutionsQ1 2023: 41 institutionsQ2 2023: 36 institutionsQ3 2023: 32 institutionsQ4 2023: 3 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $18.7M
Q1 2021: $25.7MQ2 2021: $14.5MQ3 2021: $11.9MQ4 2021: $18.7MQ1 2022: $27.8MQ2 2022: $22.2MQ3 2022: $50.5MQ4 2022: $28.0MQ1 2023: $28.7MQ2 2023: $13.5MQ3 2023: $1.57MQ4 2023: $613Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RVLP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20233$613
Q3 202332$1.57M
Q2 202336$13.5M
Q1 202341$28.7M
Q4 202236$28.0M
Q3 202246$50.5M
Q2 202238$22.2M
Q1 202236$27.8M
Q4 202131$18.7M
Q3 202135$11.9M
Q2 202146$14.5M
Q1 202155$25.7M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q3 2021.

Institutions holding RVLP in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Athyrium Capital Management, LP8,148,832$8.80M3.14%+8,148,832New
Rovida Advisors Inc.3,000,000$3.21M0.14%+2,436,447+432.3%Added
Morgan Stanley1,366,028$1.48M0.00%−56,747−4.0%Reduced
Renaissance Technologies LLC1,355,774$1.46M0.00%+438,725+47.8%Added
Alyeska Investment Group, L.P.1,125,689$1.22M0.01%+1,125,689New
ArrowMark Colorado Holdings LLC1,000,000$1.08M0.01%+1,000,000New
Two Sigma Investments, LP249,851$270.0K0.00%+249,851New
Vanguard Group Inc207,942$225.0K0.00%−2,492−1.2%Reduced
BlackRock Inc.157,872$172.0K0.00%−12,630−7.4%Reduced
Geode Capital Management, LLC143,662$155.0K0.00%−2,770−1.9%Reduced
Titleist Asset Management, Ltd.80,184$87.0K0.02%+80,184New
Dimensional Fund Advisors LP72,623$78.0K0.00%−2,155−2.9%Reduced
Deutsche Bank AG70,524$76.0K0.00%−579−0.8%Reduced
Two Sigma Advisers, LP63,200$68.0K0.00%+63,200New
Northern Trust Corp45,390$49.0K0.00%+19,233+73.5%Added
Millennium Management LLC43,560$47.0K0.00%−84,003−65.9%Reduced
Engineers Gate Manager LP42,810$46.0K0.00%+16,890+65.2%Added
State Street Corp34,184$37.0K0.00%00.0%Unchanged
Insight Advisors, LLC24,800$27.0K0.01%00.0%Unchanged
Zebra Capital Management LLC24,384$26.0K0.04%00.0%Unchanged
Wells Fargo & Company23,750$25.0K0.00%+6,740+39.6%Added
Bank of New York Mellon Corp12,078$13.0K0.00%00.0%Unchanged
UBS Group AG2,772$3.00K0.00%−2,216−44.4%Reduced
Tower Research Capital LLC (TRC)1,685$2.00K0.00%−6,163−78.5%Reduced
Royal Bank of Canada2,386$2.00K0.00%+455+23.6%Added
Huntington National Bank1,650$2.00K0.00%+1,650New
Simplex Trading, LLC2,298$2.00K0.00%+2,298New
Advisor Group Holdings, Inc.1,187$1.00K0.00%−500−29.6%Reduced
The PNC Financial Services Group, Inc.700$1.00K0.00%00.0%Unchanged
Bank of America Corp1$00.00%−6,213−100.0%Reduced
JPMorgan Chase & Co3$00.00%−4,250−99.9%Reduced
Ergoteles LLC0$00.00%−41,349−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−27,120−100.0%Sold out
HRT Financial LP0$00.00%−22,866−100.0%Sold out
ProShare Advisors LLC0$00.00%−13,434−100.0%Sold out
Nations Financial Group Inc,0$00.00%−12,500−100.0%Sold out
Walleye Trading LLC0$00.00%−10,000−100.0%Sold out
Citigroup Inc0$00.00%−3,526−100.0%Sold out
Barclays PLC0$00.00%−2,425−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−1,299−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,440−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−43−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−140−100.0%Sold out